Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04904055 · ClinicalTrials.gov registry record
Evaluating the Impact of a Value-based Prescription Drug Formulary
A clinical trial of Value-Based Health Insurance, sponsored by Kaiser Permanente.
- Completed
- Registry status
- 36,333
- Enrollment target
- 1
- Study location
NCT04904055 is a study of Value-Based Health Insurance that has completed, run by Kaiser Permanente. The registered enrollment target is 36,333 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04904055, a study of Value-Based Health Insurance, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- 36,333 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to evaluate the impact of the value-based formulary on patient out-of-pocket spending and health plan spending as well as the impact of the value-based formulary on medication use, emergency department visits, hospitalizations, and outpatient office visits.
Conditions Studied
Interventions
- OTHER Value-based Formulary
Study Locations (1)
Washington
- Kaiser Permanente - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36,333 participants |
| Start Date | 2015-01-01 |
| Est. Completion | 2019-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04904055
The ClinicalTrials.gov registry entry for NCT04904055 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 36,333 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Value-Based Health Insurance appearing as the primary indexed condition, and to 1 intervention - of which Value-based Formulary is the first listed.
NCT04904055 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT04904055 about?
NCT04904055 is a clinical study titled "Evaluating the Impact of a Value-based Prescription Drug Formulary". The objective of this study is to evaluate the impact of the value-based formulary on patient out-of-pocket spending and health plan spending as well as the impact of the value-based formulary on medication use, emergency department visits, hospitalizations, and outpatient office visits.
What is the current status of trial NCT04904055?
This trial is currently completed. The enrollment target is 36,333 participants. The study started on 2015-01-01. Estimated completion is 2019-12-31.
What conditions does trial NCT04904055 study?
This clinical trial studies the following conditions: Value-Based Health Insurance.
What interventions are being tested in trial NCT04904055?
The interventions under investigation include: Value-based Formulary (OTHER).
Who is sponsoring clinical trial NCT04904055?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04904055 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.